| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0096 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |